ArticleTranslational oncology2025

TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers.

Kimberly J Briggs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.